| Description | 1
Day Price Change % | Market Cap | P/E | ROE % | Div. Yield %  | Long-Term
Debt to Equity | Price to Book Value | Net Profit Margin % (mrq) | Price to Free Cash Flow (mrq) |
|---|---|---|---|---|---|---|---|---|---|
| Sector: Healthcare | 0.64 | 2269.7B | 22.11 | 13.52 | 2.23 | 0.76 | 10.06 | 10.96 | 286.74 |
| Industry: Drug Manufacturers - Major (More Info) | 0.29 | 1098.6B | 16.20 | 19.60 | 3.70 | 0.55 | 9.72 | 16.80 | 152.20 |
| Companies | |||||||||
| Schering-Plough Corp. (SGP) | 0.68 | 31.4B | NA | NA | 1.40 | 0.89 | 3.67 | 8.86 | NA |
| Abbott Laboratories (ABT) | 0.81 | 88.6B | 21.41 | NA | 2.50 | 0.73 | 4.93 | 18.07 | NA |
| Novartis AG (NVS) | -1.52 | 133.4B | 10.96 | 14.80 | 2.50 | 0.21 | 2.58 | 20.46 | 144.66 |
| Wyeth (WYE) | 1.43 | 60.6B | 13.57 | 26.56 | 2.50 | 0.60 | 3.14 | 20.96 | -246.66 |
| Aceto Corp. (ACET) | 0.55 | 179.9M | 18.82 | 7.58 | 2.70 | 0.00 | 1.34 | 3.35 | -16.66 |
| Johnson & Johnson (JNJ) | 0.54 | 194.5B | 16.75 | NA | 2.70 | 0.25 | 4.26 | 20.23 | NA |
| Sanofi-Aventis (SNY) | 1.43 | 97.5B | 12.65 | NA | 3.10 | 0.13 | 1.40 | 25.80 | NA |
| Eli Lilly & Co. (LLY) | -0.40 | 54.4B | 14.88 | 26.54 | 3.90 | 0.32 | 3.65 | 22.14 | 117.93 |
| AstraZeneca plc (AZN) | 0.84 | 68.0B | 12.48 | 38.69 | 4.00 | 1.02 | 4.62 | 19.58 | -269.76 |
| Glaxosmithkline plc (GSK) | -0.80 | 121.3B | 12.92 | 54.40 | 4.40 | 1.84 | 8.22 | 21.89 | 120.08 |
| Merck & Co. Inc. (MRK) | 1.43 | 70.1B | 14.69 | 25.65 | 4.70 | 0.23 | 3.59 | 56.73 | -66.36 |
| Bristol-Myers Squibb Co. (BMY) | 0.09 | 43.8B | 20.56 | 19.46 | 5.60 | 0.61 | 4.15 | 12.76 | 51.64 |
| Pfizer Inc. (PFE) | 0.43 | 127.8B | 17.20 | 10.92 | 6.80 | 0.25 | 1.90 | 23.50 | -198.86 |
| AP Pharma Inc. (APPA) | 10.29 | 46.2M | NA | -141.57 | NA | NA | 2.01 | NA | -9.10 |
| APP Pharmaceuticals, Inc. (APPX) | -0.13 | 3.7B | 115.72 | 15.73 | NA | NA | NA | 6.18 | 105.20 |
| Avigen Inc. (AVGN) | -0.92 | 95.9M | NA | -43.92 | NA | 0.11 | 1.50 | NA | -18.56 |
| Chem Rx Corporation (CHRX.OB) | -5.56 | 58.6M | 36.96 | 3.02 | NA | 2.17 | 0.90 | -0.44 | -13.01 |
| CPEX Pharmaceuticals, Inc. (CPEX) | -2.66 | NA | NA | NA | NA | NA | NA | -14.90 | NA |
| Evotec AG (EVTC) | 1.49 | 370.1M | NA | -36.18 | NA | 0.07 | 1.05 | -189.25 | -16.63 |
| GeoPharma Inc. (GORX) | -1.25 | 37.5M | NA | -24.84 | NA | 0.67 | 1.07 | -11.30 | -8.72 |
| HST Global, Inc. (HSTC.OB) | 21.67 | NA | NA | NA | NA | NA | NA | NA | NA |
| Inhibiton Therapeutics, Inc. (IHBT.OB) | 0.00 | 1.5M | NA | NA | NA | NA | NA | NA | -23.13 |
| Javelin Pharmaceuticals, Inc. (JAV) | 2.63 | 114.9M | NA | -177.69 | NA | NA | 4.46 | NA | -15.05 |
| Keryx Biopharmaceuticals Inc. (KERX) | 2.50 | 17.9M | NA | -177.27 | NA | NA | 1.65 | NA | -0.76 |
| Minrad International Inc. (BUF) | 7.69 | 89.0M | NA | -74.74 | NA | 0.70 | 4.58 | -26.85 | -8.14 |
| Neurologix Inc. (NRGX.OB) | -5.66 | 13.8M | NA | -51.09 | NA | NA | 0.75 | NA | -8.04 |
| Novogen Limited (NVGN) | 11.32 | 116.5M | NA | -41.62 | NA | NA | 2.90 | -140.78 | -29.90 |
| Oscient Pharmaceuticals Corp. (OSCI) | 2.05 | 21.0M | NA | NA | NA | NA | NA | -116.61 | -5.73 |
| Provectus Pharmaceuticals, Inc (PVCT.OB) | 7.87 | 48.5M | NA | -67.71 | NA | NA | 3.61 | NA | -26.48 |
| Quick-Med Technologies Inc. (QMDT.OB) | 60.00 | 12.3M | NA | NA | NA | NA | NA | -146.70 | -45.32 |
| Rigel Pharmaceuticals, Inc. (RIGL) | 3.63 | 875.5M | NA | -64.36 | NA | 0.01 | 4.62 | NA | -37.71 |
| Spectrum Pharmaceuticals, Inc. (SPPI) | -1.37 | 45.3M | NA | -84.94 | NA | NA | 1.10 | NA | -7.17 |
| Tetragenex Pharmaceuticals, In (TTRX.OB) | 0.00 | 3.8M | NA | NA | NA | NA | NA | NA | -41.73 |
| Vertical Health Solutions Inc. (VHSL.OB) | 0.00 | 0.3M | NA | NA | NA | NA | NA | NA | NA |
| WuXi PharmaTech (Cayman) Inc. (WX) | -2.68 | 1.2B | 34.91 | 23.72 | NA | 0.18 | 4.16 | 24.29 | NA |
| Znomics, Inc. (ZNOM.OB) | 0.00 | 26.0M | NA | NA | NA | NA | 9.14 | NA | -50.85 |